Literature DB >> 19347873

Cell-cycle-dependent PC-PLC regulation by APC/C(Cdc20)-mediated ubiquitin-proteasome pathway.

Da Fu1, Yushui Ma, Wei Wu, Xuchao Zhu, Chengyou Jia, Qianlei Zhao, Chunyi Zhang, Xing Zhong Wu.   

Abstract

Phosphatidylcholine-specific phospholipase C (PC-PLC) is involved in the cell signal transduction, cell proliferation, and apoptosis. The mechanism of its action, however, has not been fully understood, particularly, the role of PC-PLC in the cell cycle. In the present study, we found that cell division cycle 20 homolog (Cdc20) and PC-PLC were co-immunoprecipitated reciprocally by either antibody in rat hepatoma cells CBRH-7919 as well as in rat liver tissue. Using confocal microscopy, we found that PC-PLC and Cdc20 were co-localized in the perinuclear endoplasmic reticulum region (the "juxtanuclear quality control" compartment, JUNQ). The expression level and activities of PC-PLC changed in a cell-cycle-dependent manner and were inversely correlated with the expression of Cdc20. Intriguingly, Cdc20 overexpression altered the subcellular localization and distribution of PC-PLC, and caused PC-PLC degradation by the ubiquitin proteasome pathway (UPP). Taken together, our data indicate that PC-PLC regulation in cell cycles is controlled by APC/C(Cdc20)-mediated UPP. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347873     DOI: 10.1002/jcb.22163

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

Review 1.  Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher; A Gusain
Journal:  Neurochem Res       Date:  2011-11-22       Impact factor: 3.996

2.  Losartan treatment attenuates tumor-induced myocardial dysfunction.

Authors:  Sarah C W Stevens; Markus Velten; Dane J Youtz; Yvonne Clark; Runfeng Jing; Peter J Reiser; Sabahattin Bicer; Raymond D Devine; Donna O McCarthy; Loren E Wold
Journal:  J Mol Cell Cardiol       Date:  2015-05-16       Impact factor: 5.000

Review 3.  Processive ubiquitin chain formation by the anaphase-promoting complex.

Authors:  Hermann-Josef Meyer; Michael Rape
Journal:  Semin Cell Dev Biol       Date:  2011-04-06       Impact factor: 7.727

4.  Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma.

Authors:  Hui-Deng Long; Yu-Shui Ma; Hui-Qiong Yang; Shao-Bo Xue; Ji-Bin Liu; Fei Yu; Zhong-Wei Lv; Ji-Yu Li; Ru-Ting Xie; Zheng-Yan Chang; Gai-Xia Lu; Wen-Ting Xie; Da Fu; Li-Juan Pang
Journal:  Mol Biol Rep       Date:  2018-10-19       Impact factor: 2.316

5.  Overlapping Yet Response-Specific Transcriptome Alterations Characterize the Nature of Tobacco-Pseudomonas syringae Interactions.

Authors:  Zoltán Bozsó; Péter G Ott; Evelin Kámán-Tóth; Gábor F Bognár; Miklós Pogány; Ágnes Szatmári
Journal:  Front Plant Sci       Date:  2016-03-07       Impact factor: 5.753

6.  Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy.

Authors:  Franca Podo; Luisa Paris; Serena Cecchetti; Francesca Spadaro; Laura Abalsamo; Carlo Ramoni; Alessandro Ricci; Maria Elena Pisanu; Francesco Sardanelli; Rossella Canese; Egidio Iorio
Journal:  Front Oncol       Date:  2016-08-02       Impact factor: 6.244

7.  Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells.

Authors:  Laura Mercurio; Serena Cecchetti; Alessandro Ricci; Aurora Pacella; Giovanni Cigliana; Giuseppina Bozzuto; Franca Podo; Egidio Iorio; Giulia Carpinelli
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

8.  High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1.

Authors:  Yu-Shui Ma; Ting-Miao Wu; Zhong-Wei Lv; Gai-Xia Lu; Xian-Ling Cong; Ru-Ting Xie; Hui-Qiong Yang; Zheng-Yan Chang; Ran Sun; Li Chai; Ming-Xiang Cai; Xiao-Jun Zhong; Jian Zhu; Da Fu
Journal:  Oncotarget       Date:  2017-02-14

9.  Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis.

Authors:  Yu-Shui Ma; Kai-Jian Chu; Chang-Chun Ling; Ting-Miao Wu; Xu-Chao Zhu; Ji-Bin Liu; Fei Yu; Zhi-Zhen Li; Jing-Han Wang; Qing-Xiang Gao; Bin Yi; Hui-Min Wang; Li-Peng Gu; Liu Li; Lin-Lin Tian; Yi Shi; Xiao-Qing Jiang; Da Fu; Xiong-Wen Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2020-06-01       Impact factor: 8.886

10.  MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.

Authors:  Yu-Shui Ma; Zhong-Wei Lv; Fei Yu; Zheng-Yan Chang; Xian-Ling Cong; Xiao-Ming Zhong; Gai-Xia Lu; Jian Zhu; Da Fu
Journal:  J Exp Clin Cancer Res       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.